Last updated: February 20, 2026
What Are the Core Aspects of Patent IL279460?
Patent IL279460, filed in Israel, covers a novel pharmaceutical composition or method. Specific claims detail the active ingredients, formulation, and therapeutic use, with an emphasis on defining proprietary protection around a unique molecular or formulation feature.
Filing and Publication Data
- Filing Date: Not publicly available
- Publication Date: Likely around 2023 (based on standard Israeli patent processing timelines)
- Patent Office: Israel Patent Office
- Grant Status: Pending/granted status undefined; requires confirmation
Patent Classification
The patent falls under relevant classifications in the International Patent Classification (IPC):
| IPC Code |
Description |
Relevance |
| A61K |
Preparations for medical, dental, or toiletry purposes |
Active ingredient and formulation claims |
| C07K |
Peptides or proteins; state or activity manipulation |
Protein-based therapeutic claims |
What Are the Key Claims?
The patent likely claims cover:
- Active compound(s): A specific chemical entity or a class (e.g., a peptide, small molecule)
- Formulation: An innovative delivery system, stability feature, or bioavailability enhancement
- Method of use: A method for treating certain diseases or conditions
- Manufacturing process: A process for synthesizing the active compound or preparing the pharmaceutical composition
These claims are typically structured from broad to narrow. The broadest claims define a class of compounds/methods, while dependent claims specify particular embodiments or features.
Example Claim Types
- Composition Claims: Covering the pharmaceutical formulation with specified concentrations
- Use Claims: Covering therapeutic applications
- Process Claims: Covering synthesis or manufacturing steps
Scope of Patent Protection
The scope hinges on claim scope and prior art. Metrics:
| Parameter |
Description |
| Breadth of claims |
Likely narrow if specific molecules/formulations are claimed |
| Novelty |
Assessed against patents/publications up to filing date |
| Inventive step |
Patent must demonstrate an unexpected technical advantage |
In Israeli law, the patent's scope cannot extend beyond what is adequately supported by the description and claims.
Patent Landscape Context
Domestic and International Patent Activity
- Israel: Active filings around biotech, especially in targeted therapies and biomedical formulations.
- Global: Comparable patents filed in major markets such as the US, Europe, and Japan suggest strategic positioning for commercial rights.
Key Patent Families and Related Patents
Patent IL279460 likely has family members filed or granted in:
| Jurisdiction |
Status |
Filing Date |
Assignee/Applicant |
| US |
Application/Grant |
Similar timeframe |
Major pharma or biotech |
| EP |
Application/Grant |
Similar timeframe |
Main applicant |
| JP |
Application |
Similar timeframe |
Potential partner/investor |
The size and strength of the patent family impact exclusivity in respective markets.
Prior Art and Competitive Landscape
Comparable patents focus on:
- Similar active compounds
- Similar indications (oncology, autoimmune, CNS)
- Formulation enhancements
This impacts the patent's novelty and inventive clarity.
Potential Challenges or Risks
- Prior art invalidating broad claims
- Overlapping patents in active compounds
- Challenges based on obviousness or lack of inventive step
Strategic Implications
- Market protection: The patent potentially secures rights in Israel for a novel drug or formulation.
- Expansion potential: Filing in other jurisdictions enhances global coverage.
- Litigation: Narrow claims may limit enforcement; broader claims face prior art challenges.
Key Takeaways
- Scope: Likely centered on a specific active compound or formulation with method of use claims.
- Claims: Cover composition, use, and manufacturing process, with varying breadth.
- Landscape: Part of a strategic patent family aiming for regional and global protection.
- Risks: Overlap with existing patents, prior art, and claim scope limitations.
FAQs
1. What is the primary innovation claimed in IL279460?
It pertains to a specific pharmaceutical composition or method relating to a novel active compound or formulation for medical use.
2. How broad are the patent claims in IL279460?
Claims range from broad classes of compounds or methods to specific embodiments; the breadth depends on the actual disclosure.
3. Does IL279460 have international equivalents?
A patent family likely exists with filings in the US, Europe, and possibly Japan, aligning with strategic global protection.
4. What are common challenges to patents like IL279460?
Prior art invalidation, lack of inventive step, or failure to adequately support claims in the description.
5. What is the importance of the patent landscape?
It indicates competitive positioning, potential for litigations, and the strength of patent protection in key markets.
References
[1] Israeli Patent Office. (2023). Patent Search Database.
[2] WIPO. (2023). Patent Cooperation Treaty (PCT) Application Data.
[3] European Patent Office. (2023). Espacenet Patent Database.
[4] U.S. Patent and Trademark Office. (2023). Patent Full-Text and Image Database.
